Skip to Main Content Skip to Main Content

HSC Medicine, Dentistry and Healthcare Sciences Current Awareness Bulletins: Guidelines and Cochrane Reviews

Guidelines and Cochrane Reviews

Frequency: Monthly

Links to articles in the current and previous 2 issues of this bulletin are displayed below.

To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk

February 2025

All content new, unless marked as ‘updated’

Cochrane reviews

Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women (updated)

Ankle‐foot orthoses for improving walking in adults with calf muscle weakness due to neuromuscular disorders

Antidepressants versus placebo for generalised anxiety disorder (GAD)

Anti‐PD‐1 and anti‐PD‐L1 antibodies for glioma

Caesarean myomectomy in pregnant women with uterine fibroids

Calorie (energy) labelling for changing selection and consumption of food or alcohol

Differences in the effectiveness of individual‐level smoking cessation interventions by socioeconomic status

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair

Diuretics for preventing and treating acute kidney injury

Electronic cigarettes for smoking cessation (updated)

Gonadotropin‐releasing hormone agonist protocols for pituitary suppression in assisted reproduction (updated)

Incentives for smoking cessation (updated)

Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion

Interventions for quitting vaping

Interventions implemented through sporting organisations for promoting healthy behaviour or improving health outcomes

Interventions to reduce non‐prescription antimicrobial sales in community pharmacies

Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis (updated)

Lurasidone versus typical antipsychotics for schizophrenia

Oral and intranasal aspirin desensitisation for non‐steroidal anti‐inflammatory drug (NSAID)‐exacerbated respiratory disease

Precision nutrition‐based interventions for the management of obesity in children and adolescents up to the age of 19 years

Preservation of the azygos vein versus ligation of the azygos vein during primary surgical repair of congenital esophageal atresia

Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients (updated)

Tests for diagnosis of postpartum haemorrhage at vaginal birth

Thrombolysis for aneurysmal subarachnoid haemorrhage

Tranexamic acid for preventing postpartum haemorrhage after vaginal birth (updated)

Virtual reality for multiple sclerosis rehabilitation

NICE guidelines

Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (TA697 – updated)

Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumours (TA1034)

Artificial intelligence technologies to help detect fractures on X-rays in urgent care: early value assessment (HTE20)

Digitally enabled therapies for adults with depression: early value assessment (HTE8 - updated)

Durvalumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancer (TA1030)

Electrically stimulated intravesical therapy for interstitial cystitis or overactive bladder in adults (IPG799)

Epilepsies in children, young people and adults (NG217 – updated)

Gambling-related harms: identification, assessment and management (NG248)

Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years (NG247)

Overweight and obesity management (NG246)

Tebentafusp for treating advanced uveal melanoma (TA1027)

Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasia (IPG798)

Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease (TA1035)

Vamorolone for treating Duchenne muscular dystrophy in people 4 years and over (TA1031)

Sources

Cochrane Library (Jan); NICE website (Jan)

January 2025

All content new unless specified as updated

Cochrane reviews

Azathioprine for people with multiple sclerosis

Cell salvage for the management of postpartum haemorrhage

Chemotherapy and radiotherapy for advanced pancreatic cancer (updated)

Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women (updated)

Cycled light in the intensive care unit for preterm and low birth weight infants (updated)

Diagnostic test accuracy of self‐administered cognitive assessment tools for dementia

Effect and safety of intravenous iron compared to oral iron for treatment of iron deficiency anaemia in pregnancy

The effect of sample site and collection procedure on identification of SARS‐CoV‐2 infection

Exercise therapy for chronic fatigue syndrome

Fluid restriction for treatment of symptomatic patent ductus arteriosus in preterm infants

Gender differences in the context of interventions for improving health literacy in migrants: a qualitative evidence synthesis

Higher blood pressure targets for hypertension in older adults

Non‐steroidal anti‐inflammatory drugs for treating symptomatic uncomplicated urinary tract infections in non‐pregnant adult women

Oocyte activation for women following intracytoplasmic sperm injection (ICSI)

Prevention of self‐harm and suicide in young people up to the age of 25 in education settings

Sex and gender as predictors for allograft and patient‐relevant outcomes after kidney transplantation

Standard‐ versus extended‐duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients

Strategies for enhancing the implementation of school‐based policies or practices targeting diet, physical activity, obesity, tobacco or alcohol use

Treatment for women with postpartum iron deficiency anaemia (updated)

Unintended consequences of measures implemented in the school setting to contain the COVID‐19 pandemic: a scoping review

NICE guidelines

Bevacizumab gamma for treating wet age-related macular degeneration (TA1022)

Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer (TA1021)

Digital technologies to support self-management of COPD: early value assessment (HTE19)

Direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implant (IPG795)

Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatments (TA1023)

Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome (DG62)

Meningitis (bacterial) and meningococcal disease (QS19 - updated)

MRI-guided focused ultrasound subthalamotomy for treating Parkinson's (IPG797)

MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson's (IPG796)

Tirzepatide for managing overweight and obesity (TA1026)

Ublituximab for treating relapsing multiple sclerosis (TA1025)

Urinary tract infection (recurrent): antimicrobial prescribing (NG112 – updated)

Sources

Cochrane Library (Dec); NICE website (Dec)

December 2024

All content new unless marked as updated

Cochrane reviews

Biosimilar monoclonal antibodies for cancer treatment in adults

Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults (updated)

Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes (updated)

Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early‐stage Hodgkin’s lymphoma (updated)

Excisional surgery versus ablative surgery for ovarian endometrioma (updated)

Fenoldopam for preventing and treating acute kidney injury

Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment (updated)

Hyaluronidase for reducing perineal trauma (updated)

Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric patients undergoing surgery for congenital heart disease: a network meta‐analysis

Low dialysate sodium levels for chronic haemodialysis (updated)

Non‐corticosteroid immunosuppressive medications for steroid‐sensitive nephrotic syndrome in children (updated)

Omega‐3 fatty acid supplementation for depression in children and adolescents

Prophylactic use of inotropic agents for the prevention of low cardiac output syndrome and mortality in adults undergoing cardiac surgery

Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy (updated)

Resistance training for fatigue in people with cancer

Serum and urine nucleic acid screening tests for BK polyomavirus‐associated nephropathy in kidney and kidney‐pancreas transplant recipients

Single‐incision versus conventional multi‐incision laparoscopic appendicectomy for suspected uncomplicated appendicitis (updated)

Statins for the primary prevention of venous thromboembolism

Time to publication for results of clinical trials

Topical silver diamine fluoride (SDF) for preventing and managing dental caries in children and adults

Tranexamic acid for preventing postpartum haemorrhage after caesarean section

NICE guidelines

Alectinib for adjuvant treatment of ALK-positive non-small-cell lung cancer (TA1014)

Asthma pathway (BTS, NICE, SIGN) (NG244)

Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (NG245)

Avapritinib for treating advanced systemic mastocytosis (TA1012)

Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and over (TA1019)

Elafibranor for previously treated primary biliary cholangitis (TA1016)

Endometriosis: diagnosis and management (NG73 – updated)

Endoscopic bipolar radiofrequency ablation for malignant biliary obstruction (IPG794)

Eplontersen for treating hereditary transthyretin-related amyloidosis (TA1020)

Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis (TA1018)

Menopause: identification and management (NG23 – updated)

Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancer (TA1017)

Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatments (TA1015)

SIGN guidelines

Asthma: diagnosis, monitoring and chronic asthma management (SIGN245)

British guideline on the management of asthma (SIGN158 – updated)

Sources

Cochrane Library (Nov); NICE website (Nov); SIGN website (Nov)

Disclaimer

The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.